MedTrace Logo

Screening for Sleep Apnea in Patients Undergoing Atrial Fibrillation Ablation

NCT02332096 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2020-08-05

No results posted yet for this study

Summary

Diagnosis and treatment of sleep apnea with continuous positive airway pressure (CPAP) therapy has been shown to decrease arrhythmia recurrence in patients with AF following ablation. However, patients with AF undergoing ablation are not routinely screened for sleep apnea, despite an estimated sleep apnea prevalence of 25% in the general population, and perhaps higher among patients with AF. Home sleep testing is frequently used for evaluation of sleep apnea.

Conditions

Interventions

DEVICE

Home Sleep Testing Device

Patients will undergo obstructive sleep apnea screening with a FDA approved home sleep testing device.

Sponsors & Collaborators

Principal Investigators

  • Patricia Tung, MD · Beth Israel Deaconess Medical Center, Harvard Medical School

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2020-02-07
Completion
2020-02-07

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02332096 on ClinicalTrials.gov